Sign in

Clay Hoffman

Research Analyst at Nicholas Hoffman & Company, LLC.

Clay Hoffman is an Analyst at Invitation Homes, specializing in real estate and investment analysis within the residential rental sector. During his tenure, he has evaluated assets for one of the largest single-family home leasing companies in the United States and contributed insights on regional investment opportunities. Hoffman began his career with roles at Mynd and later joined Invitation Homes, further advancing his expertise in investment management for institutional real estate portfolios. He holds relevant professional credentials corresponding to his responsibilities, with a background that spans management and analytical roles in real estate investment.

Clay Hoffman's questions to CHAMPIONS ONCOLOGY (CSBR) leadership

Question · Q1 2026

Clay Hoffman sought an update on Q2 fiscal 2026 revenue performance compared to the previous year, given the quarter was approximately halfway complete.

Answer

CFO David Miller confirmed that management has a good understanding of Q2 revenue but declined to provide specific guidance on exact numbers or percentages at this time. He reiterated the expectation for sequential quarterly revenue increases.

Ask follow-up questions

Question · Q1 2026

Clay Hoffman requested an update on Q2 revenue performance compared to the previous year, given that the company was halfway through the quarter.

Answer

CFO David Miller stated that while the company has a good handle on Q2 revenue, specific guidance on exact numbers or percentages would not be provided. He reiterated the expectation for sequential quarterly revenue increases.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts

Question · Q1 2026

Clay Hoffman requested an update on Champions Oncology's Q2 fiscal 2026 revenue performance, specifically asking for color on how it compares to the previous year, given that the company was halfway through the quarter.

Answer

CFO David Miller stated that while the company has a good handle on Q2 revenue, they are not providing specific guidance at this time. He reiterated the anticipation of quarterly revenue increases but declined to give exact numbers or percentages for the upcoming quarter.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts